Acute bronchitis
Overview
Acute bronchitis is an acute inflammatory condition of the bronchi/bronchioles, almost always viral and self-limiting. The key clinical skill is knowing when NOT to prescribe antibiotics.
Presentation
•Cough - cardinal symptom; initially dry, may become productive (clear/yellow-green sputum)
•Wheeze - bronchospasm from airway inflammation
•Mild malaise, low-grade fever, chest tightness
•Examination - scattered rhonchi; crackles that clear with coughing (unlike pneumonia)
Investigations
Acute bronchitis is a clinical diagnosis - investigations are not routinely required in a well patient.
•CRP (point-of-care) - most useful investigation; guides antibiotic prescribing decision
•Chest X-ray - only if pneumonia suspected (focal signs, significant systemic upset, failure to improve)
•Pulse oximetry - if breathlessness is prominent
Management
🥇 First-line
•reassurance and self-care - viral illness, antibiotics unlikely to help, resolves within 3 weeks in most cases
•Symptomatic measures - hydration, rest, paracetamol/ibuprofen, honey for cough
•Smoking cessation advice where applicable
CRP | Action |
< 20 mg/L | No antibiotics |
20-100 mg/L | Delayed prescription - use if not improving after 3-5 days |
> 100 mg/L | Immediate antibiotic prescription |
•Antibiotic of choice: doxycycline (NICE 2022)
•Immediate antibiotics also indicated if: age >65 with comorbidities, significantly unwell, or higher risk of complications
Complications
•Progression to community-acquired pneumonia - key complication; more likely in elderly, significant comorbidities, or immunocompromised
•Exacerbation of underlying lung disease - asthma, COPD, or bronchiectasis
•Post-infective cough - persistent dry cough weeks beyond acute illness
Safety-netting and follow-up
•Routine follow-up not necessary - safety-netting is the priority
•Return if: symptoms worsen rapidly, fail to improve within expected timeframe, or new focal signs develop
•Warn patients: residual dry cough can persist for up to 3 weeks (post-infective airway hyper-reactivity)